Skip to main content
رجوع
TSHA logo

Taysha Gene Therapies, Inc.

جودة البيانات: 100%
TSHA
NASDAQ Healthcare Biotechnology
KWD 4.54
▲ KWD 0.14 (3.18%)
القيمة السوقية: 1.08B
نطاق اليوم
KWD 4.37 KWD 4.54
نطاق 52 أسبوعًا
KWD 1.05 KWD 6.02
حجم التداول
1,694,192
متوسط 50 يوم / 200 يوم
KWD 4.65 / KWD 3.96
الإغلاق السابق
KWD 4.40

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -9.9 0.4
P/B 4.4 2.9
ROE % -68.5 3.8
Net Margin % -1115.3 3.9
Rev Growth 5Y % 10.0
D/E 0.1 0.2

النقاط الرئيسية

Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -93.83M
Capital efficient — spends only 7.55% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)17.28%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-68.45%
ROIC-31.26%
Net Margin-1115.27%
Op. Margin-1130.65%

الأمان

Debt / Equity
0.07
Current Ratio12.23
Interest Coverage-1753.94

التقييم

P/E Ratio
-9.94
P/B Ratio4.39
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 17.28% Revenue Growth (3Y) -20.47%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 9.77M Net Income (TTM) -109.00M
ROE -68.45% ROA -31.75%
Gross Margin 88.28% Operating Margin -1130.65%
Net Margin -1115.27% Free Cash Flow (TTM) -93.83M
ROIC -31.26% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.07 Current Ratio 12.23
Interest Coverage -1753.94 Dividend Yield 0.00%
Valuation
P/E Ratio -9.94 P/B Ratio 4.39
P/S Ratio 110.81 PEG Ratio 2.90
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.08B Enterprise Value 781.36M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 9.77M 8.33M 15.45M 2.50M 0.0
Net Income -109.00M -89.30M -111.57M -166.01M -174.52M
EPS (Diluted) -0.34 -0.36 -0.96 -3.78 -4.64
Gross Profit 8.63M 8.33M 15.45M 14,999.0 0.0
Operating Income -110.50M -91.46M -72.44M -126.03M -173.27M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 343.32M 160.36M 172.73M 126.28M 213.96M
Total Liabilities 96.38M 88.84M 97.79M 125.33M 118.57M
Shareholders' Equity 246.94M 71.53M 74.94M 949,000.0 95.38M
Total Debt 18.17M 63.18M 61.11M 59.93M 63.09M
Cash & Equivalents 319.77M 139.04M 143.94M 87.88M 149.10M
Current Assets 324.65M 142.13M 149.87M 96.42M 159.60M
Current Liabilities 26.55M 26.23M 36.76M 62.79M 51.75M